Potential amelioration of morbidity in patients with chromosomal anomalies: Relevance to Bardet-Biedl syndrome

Clinical Genetics

Volumn 79, Issue 5, 2011, Pages 482-488

  Genuis, S J ^a   Lobo, R A ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Bardet; Biedl syndrome; Chromosomal anomaly; Nutrition

Indexed keywords

5 HYDROXYTRYPTOPHAN; ARGININE; FOLIC ACID; SEROTONIN UPTAKE INHIBITOR; TYROSINE; UBIDECARENONE; VITAMIN B COMPLEX;

AMINO ACID METABOLISM; ANAMNESIS; ARTICLE; BARDET BIEDL SYNDROME; BEHAVIOR DISORDER; CASE REPORT; CHILD; CHROMOSOME ABERRATION; DEVELOPMENTAL DISORDER; DIET SUPPLEMENTATION; ECHOGRAPHY; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; LABORATORY TEST; MALADJUSTMENT; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; OBESITY; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

BARDET-BIEDL SYNDROME; BLINDNESS; CHROMOSOME DISORDERS; FEMALE; HUMANS; INFANT; MORBIDITY;

EID: 79953733511     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01475.x     Document Type: Article

References (51)

1. Laurence J, Moon RC. Four cases of retinitis pigmentosa occurring in the same family accompanied by general imperfection of development. Opthalamol Rev 1866: 2: 32-41.
2. Bardet G. Sur un syndrome d'obesite congenitale avec polydactylie et retinite pigmentaire (contribution a l'etude des formes cliniques de l'obesite hypophysaire). Thesis no. 470, Paris, France: Universite de Paris, Amedee LeGrand, 1920.
3. Biedl A. Ein Geschwitsterpaar mit adipose-genitaler Dystrophie. Dtsch Med Wochenschr 1922: 48: 1630.
4. Green JS, Parfrey PS Harnett JD et al. The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med 1989: 321 (15): 1002-1009.
5. Beales PL, Warner AM, Hirman GA, Thakker R, Flinter FA. Bardet-Biedl syndrome: a molecular and phenotypic study of 18 families. J Med Genet 1997: 34 (2): 92-98.
6. Beales PL, Elcioglu N, Woolf AS, Parker D, Flinter FA. New criteria from improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J Med Genet 1999: 36 (6): 437-446.
7. Barnett S, Reilly S, Carr L, Ojo I, Beales PL, Charman T. Behavioural phenotype of Bardet-Biedl syndrome. J Med Genet 2002: 39 (12): e76.
8. Cherian MP, Al-Sanna'a NA. Clinical spectrum of Bardet-Biedl syndrome among four Saudi Arabian families. Clin Dysmorphol 2009: 18 (4): 188-194.
9. Klein D, Ammann F. The syndrome of Laurence-Moon-Bardet-Biedl and allied diseases in Switzerland. Clinical, genetic and epidemiological studies. J Neurol Sci 1969: 9 (3): 479-513.
10. Farag TI, Teebi AS. Bardet-Biedl and Laurence-Moon syndromes in a mixed Arab population. Clin Genet 1988: 33 (2): 78-82.
11. Farag TI, Teebi AS. High incidence of Bardet-Biedl syndrome among the Bedouin. Clin Genet 1989: 36 (6): 463-464.
12. Katsanis N, Ansley SJ, Badano JL et al. Triallelic inheritance in Bardet-Biedl syndrome: a Mendelian recessive disorder. Science 2001: 293 (5538): 2256-2259.
13. Beales PL, Badano JL, Ross AJ et al. Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in non-Mendelian Bardet-Biedl syndrome. Am J Hum Genet 2003: 72 (5): 1187-1199.
14. Kulaga HM, Leitch CC, Eichers ER et al. Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse. Nat Genet 2004: 36 (9): 994-998.
15. Nishimura DY, Fath M, Mullins RF et al. Bbs2-null mice have neurosensory deficits, a defect in social dominance, and retinopathy associated with mislocalization of rhodopsin. Proc Natl Acad Sci U S A 2004: 101 (47): 16588-16593.
16. Fan Y, Esmail MA, Ansley SJ et al. Mutations in a member of the Ras superfamily of small GTP-binding proteins causes Bardet-Biedl syndrome. Nat Genet 2004: 36 (9): 989-993.
17. Kim JC, Badano JL, Sibold S et al. The Bardet-Biedl protein BBS4 targets cargo to the pericentriolar region and is required for microtubule anchoring and cell cycle progression. Nat Genet 2004: 36 (5): 462-470.
18. Li JB, Gerdes JM, Haycraft C et al. Comparative genomics identifies a flagellar and basal body proteome that Includes the BBS5 human disease gene. Cell 2004: 117 (4): 541-552.
19. Kim JC, Ou YY, Badano JL et al. MKKS/BBS6, a divergent chaperonin-like protein linked to the obesity disorder Bardet-Biedl syndrome, is a novel centrosomal component required for cytokinesis. J Cell Sci 2005: 118 (5): 1007-1020.
20. Blacque OE, Reardon MJ, Li C et al. Loss of C. elegans BBS-7 and BBS-8 protein function results in cilia defects and compromised intraflagellar transport. Genes Dev 2004: 18 (13): 1630-1642.
21. Nishimura DY, Swiderski RE, Searby CC et al. Comparative genomics and gene expression analysis identifies BBS9: a new Bardet-Biedl syndrome gene. Am J Hum Genet 2005: 77 (6): 1021-1033.
22. Stoetzel C, Laurier V, Davis EE et al. BBS10 encodes a vertebrate-specific chaperonin-like protein and is a major BBS locus. Nat Genet 2006: 38 (5): 521-524.
23. Chiang AP, Beck JS, Yen HJ et al. Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11). Proc Natl Acad Sci U S A 2006: 103 (16): 6287-6292.
24. Stoetzel C, Muller J, Laurier V et al. Identification of a novel BBS gene (BBS12) highlights the major role of a vertebrate-specific branch of chaperonin-related proteins in Bardet-Biedl syndrome. Am J Hum Genet 2007: 80 (1): 1-11.
25. Leitch CC. Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndrome. Nat Genet 2008: 40 (4): 443-448.
26. Tobin JL, Beales PL. Bardet-Biedl syndrome: beyond the cilium. Pediatr Nephrol 2007: 22 (7): 926-936.
27. Zaghloul NA, Katsanis N. Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy. J Clin Invest 2009: 119 (3): 428-437.
28. Kulaga HM, Leitch CC, Eichers ER et al. Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse. Nat Genet 2004: 36 (9): 994-998.
29. Tan PL, Barr T, Inglis PN et al. Loss of Bardet Biedl syndrome proteins causes defects in peripheral sensory innervation and function. Proc Natl Acad Sci U S A 2007: 104 (44): 17524-17529.
30. Rooryck C, Lacombe D. Bardet-Biedl syndrome. Ann Endocrinol 2008: 69 (6): 463-471.
31. Deffert C, Niel F, Mochel F et al. Recurrent insertional polydactyly and situs inversus in a Bardet-Biedl syndrome family. Am J Med Genet A 2007: 143 (2): 208-213.
32. Riise R. The cause of death in Laurence-Moon-Bardet-Biedl syndrome. Acta Opthalmol Scand Suppl 1996: 219: 45-47.
33. Brühl P, Schwanitz G, Mallmann R, Müller SC, Raff R. Bardet-Biedl syndrome: aspects of nephro-urology and human genetics. Klin Padiatr 2001: 213 (1): 8-12.
34. Ulusoy S, Kaynar K, Gul S, Ukinc K. Renal failure due to Bardet-Biedl syndrome. A case report. Med Princ Pract 2004: 13 (6): 380-382.
35. Sahu JK, Jain V. Laurence-Moon-Bardet-Biedl syndrome. J Nepal Med Assoc 2008: 47 (172): 235-237.
36. Abdulla AB, Niloy AA, Shah TA et al. Laurence Moon Bardet Biedl Syndrome. Mymensingh Med J 2009: 18 (Suppl. 1): S124-S128.
37. Daskalakis M, Till H, Kiess W, Weiner RA. Roux-en-Y gastric bypass in an adolescent patient with Bardet-Biedl syndrome: a monogenic obesity disorder. Obes Surg 2010: 20 (1): 121-125.
38. Sharifman M, Dadkhah-Chimeh M, Einollahi B et al. Renal transplantation in patients with Bardet-Biedl syndrome. Arch Iran Med 2007: 10 (3): 339-342.
39. Genuis SJ. Medical practice and community health care in the 21st century: a time of change. Public Health 2008: 122 (7): 671-680.
40. Bralley JA, Lord RS. Laboratory Evaluations in Molecular Medicine: Nutrients, Toxicants, and Cell Regulators. Norcross, GA: The Institute for Advances in Molecular Medicine, 2005.
41. Genuis SJ. Evolution in pediatric health care. Pediatr Int 2010: DOI: 10.1111/j.1442-200X.2010.03106.x.
42. Genuis SJ. The chemical erosion of human health: adverse environmental exposure and in-utero pollution - determinants of congenital disorders and chronic disease. J Perinat Med 2006: 34: 185-195.
43. Morris SM Jr. Arginine: beyond protein. Am J Clin Nutr 2006: 83 (2): 508S-512S.
44. Lameu C, de Camargo AC, Faria M. l-Arginine signalling potential in the brain: the peripheral gets central. Recent Pat CNS Drug Discov 2009: 4 (2): 137-142.
45. Luiking YC, Engelen MP, Deutz NE. Regulation of nitric oxide production in health and disease. Curr Opin Clin Nutr Metab Care 2010: 13 (1): 97-104.
46. Molyneux SL, Young JM, Florkowski CM, Lever M, George PM. Coenzyme q10: is there a clinical role and a case for measurement? Clin Biochem Rev 2008: 29 (2): 71-82.
47. Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 2006: 147 (12): 5542-5548.
48. Tonomura Y, Hirano M, Shimada K et al. Treatable fluctuating mental impairment in a patient with Bardet-Biedl syndrome. Clin Neurol Neurosurg 2009: 111 (1): 102-104.
49. Desai A, Jha O, Iyer V, Dada R, Kumar R, Tandon N. Reversible hypogonadism in Bardet-Biedl syndrome. Fertil Steril 2009: 92 (1): 391.e13-391.e15.
50. Genuis SJ, Bouchard T. Celiac disease presenting as autism. J Child Neurol 2010: 25: 114-119.
51. Genuis SJ. Is autism reversible? Acta Paediatr 2009: 98: 1575-1578.